AbilityPharma: Accelerating Solutions for Pancreatic Cancer

Project Information

PanC-ASAP

Grant agreement ID: 954825

DOI 10.3030/954825

Closed project

EC signature date 24 June 2020

Start date 1 July 2020

End date 30 June 2023

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 3 322 666,25

EU contribution € 2 325 865,38

Coordinated by

ABILITY PHARMACEUTICALS SA
Spain